PLEXIFORM NEUROFIBROMA
Clinical trials for PLEXIFORM NEUROFIBROMA explained in plain language.
Never miss a new study
Get alerted when new PLEXIFORM NEUROFIBROMA trials appear
Sign up with your email to follow new studies for PLEXIFORM NEUROFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested to fight disfiguring tumors
Disease control Not yet recruitingThis early-stage study is testing whether combining two existing cancer drugs, cabozantinib and selumetinib, is safe and effective for shrinking painful and disfiguring tumors (plexiform neurofibromas) in people aged 16 and older with neurofibromatosis type 1 (NF1). The research …
Matched conditions: PLEXIFORM NEUROFIBROMA
Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated Apr 01, 2026 14:53 UTC
-
New drug trial offers hope for shrinking painful, untreatable tumors
Disease control Not yet recruitingThis study is testing whether an oral capsule called TQ-B3234 can shrink painful, inoperable tumors in adults with neurofibromatosis type 1 (NF1). It will compare the drug to a placebo (a dummy pill) in 177 participants over 24 weeks to see if it reduces tumor size and improves p…
Matched conditions: PLEXIFORM NEUROFIBROMA
Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC